Subscribe

Spotlight -

This Year In Medicine 2025

Mark Leick, MD

Articles by Mark Leick, MD

Selecting Donor T Cells for CAR T Therapy, With Mark B. Leick, MD

Selecting Donor T Cells for CAR T Therapy, With Mark B. Leick, MD

ByMark Leick, MD

August 20th 2026

Genetic variants tied to CAR T toxicity and expansion could guide how researchers screen healthy donors for allogeneic CAR T products.

A Genetic Signature May Predict Who Gets Sick From CAR T Cell Therapy

A Genetic Signature May Predict Who Gets Sick From CAR T Cell Therapy

ByMark Leick, MD

August 13th 2026

Germline STXBP2 variants may predict severe CAR T cell toxicity, Mark B. Leick, MD, and colleagues find

Germline Variants May Predict CAR T Cell Toxicity, With Mark Leick, MD

Germline Variants May Predict CAR T Cell Toxicity, With Mark Leick, MD

ByMark Leick, MD

August 12th 2026

New research links germline genetic variants to CAR T cell toxicity risk and expansion in lymphoma patients treated with axi-cel.

Latest Updated Articles

Trending on HCPLive

The Case for Routine Kidney Screening, With Pranav Garimella, MBBS, MPH

FDA Approves Obinutuzumab (Gazyva) for Idiopathic Nephrotic Syndrome

Zilurgisertib Receives FDA Approval for FOP in Patients 12 and Older

What The FDA Psychedelic Hearing Means for Psychiatrists

FDA Approves Baricitinib for Adolescents With Severe Alopecia Areata